Burckhardt; Susanna

Patent Applications and Registrations

Patent applications and USPTO patent grants for Burckhardt; Susanna.The latest application filed is for "novel ferroportin inhibitors".

Company Profile

4.13.21

Burckhardt; Susanna - Zurich CH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Ferroportin inhibitors Grant 11,066,399 - Durrenberger , et al. July 20, 2	2021-07-20
Novel Ferroportin Inhibitors App 20210139472 - Durrenberger; Franz ; et al.	2021-05-13
Ferroportin inhibitors Grant 11,001,579 - Durrenberger , et al. May 11, 2	2021-05-11
Ferroportin inhibitors Grant 10,738,041 - Durrenberger , et al. A	2020-08-11
Novel Ferroportin Inhibitors App 20190345151 - Durrenberger; Franz ; et al.	2019-11-14
Ferroportin inhibitors Grant 10,364,239 - Durrenberger , et al.	2019-07-30
Novel Ferroportin Inhibitors App 20180319783 - Durrenberger; Franz ; et al.	2018-11-08
Novel Ferroportin Inhibitors App 20180297991 - Durrenberger; Franz ; et al.	2018-10-18
Fe(III) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias Grant 9,943,498 - Bark , et al. April 17, 2	2018-04-17
Fe(III) Complex Compounds For The Treatment And Prophylaxis Of Iron Deficiency Symptoms And Iron Deficiency Anemias App 20160310459 - Bark; Thomas ; et al.	2016-10-27
Fe(III) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias Grant 9,452,152 - Bark , et al. September 27, 2	2016-09-27
Fe(III)-pyrazine complex compounds for treatment and prophylaxis of iron-deficiency phenomena and iron-deficiency anaemia Grant 9,439,910 - Bark , et al. September 13, 2	2016-09-13
Fe(III) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias Grant 9,422,247 - Bark , et al. August 23, 2	2016-08-23
Fe(III) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias Grant 9,394,324 - Bark , et al. July 19, 2	2016-07-19
Fe(III) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias Grant 9,248,134 - Bark , et al. February 2, 2	2016-02-02
Fe(III) Complex Compounds For The Treatment And Prophylaxis Of Iron Deficiency Symptoms And Iron Deficiency Anemias App 20160015716 - Bark; Thomas ; et al.	2016-01-21
Fe(III) Complex Compounds for the Treatment and Prophylaxis of Iron Deficiency Symptoms and Iron Deficiency Anemias App 20150313864 - Bark; Thomas ; et al.	2015-11-05
Sulfonaminoquinoline hepcidin antagonists Grant 9,102,688 - Buhr , et al. August 11, 2	2015-08-11
Fe(iii)-pyrazine Complex Compounds For Treatment And Prophylaxis Of Iron-deficiency Phenomena And Iron-deficiency Anaemia App 20150119374 - Bark; Thomas ; et al.	2015-04-30
Novel Sulfonaminoquinoline Hepcidin Antagonists App 20140364424 - Buhr; Wilm ; et al.	2014-12-11
Fe(III) 2,4-Dioxo-1-Carbonyl Complexes For Treatment And Prophylaxis Of Iron Deficiency Symptoms And Iron Deficiency Anaemias App 20140248342 - Bark; Thomas ; et al.	2014-09-04
Fe(iii) Complex Compounds For The Treatment And Prophylaxis Of Iron Deficiency Symptoms And Iron Deficiency Anemias App 20140162994 - Bark; Thomas ; et al.	2014-06-12
Fe(III) Complex Compounds For The Treatment And Prophylaxis Of Iron Deficiency Symptoms And Iron Deficiency Anemias App 20130109662 - Bark; Thomas ; et al.	2013-05-02
Novel Sulfonaminoquinoline Hepcidin Antagonists App 20120214803 - Buhr; Wilm ; et al.	2012-08-23
Novel Ethanediamone Hepcidine Antagonists App 20120214798 - Durrenberger; Franz ; et al.	2012-08-23
Novel Pyrimidine- And Triazine-Hepcidine Antagonists App 20120202806 - Durrenberger; Franz ; et al.	2012-08-09
Novel Quinoline-Hepcidine Antagonists App 20120196853 - Durrenberger; Franz ; et al.	2012-08-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.